CINDY JACOBS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CINDY JACOBS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CINDY JACOBS. CINDY JACOBS is EVP, CMO in ONCOGENEX PHARMACEUTICALS, INC. ($OGXI) and President & CMO in ACHIEVE LIFE SCIENCES, INC. ($ACHV) and Sr. VP, Clinical Development in CORIXA CORP ($CRXA).
Latest Insider Trading Transactions of CINDY JACOBS
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 28 2021 | ACHV | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | President & CMO | Option Exercise | A | 13.09 | 30,000 | 392,700 | 30,000 | |
| Jan 28 2021 | ACHV | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | President & CMO | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
| Nov 18 2020 | ACHV | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | President & CMO | Option Exercise | A | 10.36 | 12,000 | 124,320 | 12,000 | |
| Aug 19 2020 | ACHV | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 69 | 0 | 68 | |
| Aug 19 2020 | ACHV | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Payment of Exercise | F | 8.95 | 33 | 295 | 176 | 209 to 176 (-15.79 %) |
| Aug 19 2020 | ACHV | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Buy | M | 0.00 | 69 | 0 | 209 | 140 to 209 (+49.29 %) |
| Jan 30 2020 | ACHV | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Option Exercise | A | 0.56 | 200,000 | 112,000 | 200,000 | |
| Aug 15 2019 | ACHV | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 1,370 | 0 | 2,740 | |
| Aug 15 2019 | ACHV | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Payment of Exercise | F | 1.88 | 408 | 767 | 2,801 | 3.2 K to 2.8 K (-12.71 %) |
| Aug 15 2019 | ACHV | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Buy | M | 0.00 | 1,370 | 0 | 3,209 | 1.8 K to 3.2 K (+74.50 %) |
| Jan 31 2019 | OGXI | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Option Exercise | A | 1.42 | 10,000 | 14,200 | 10,000 | |
| Jan 31 2019 | OGXI | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Option Exercise | A | 1.42 | 30,000 | 42,600 | 30,000 | |
| Jan 17 2019 | OGXI | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 42 | 0 | 0 | |
| Jan 17 2019 | OGXI | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Payment of Exercise | F | 1.16 | 13 | 15 | 1,839 | 1.9 K to 1.8 K (-0.70 %) |
| Jan 17 2019 | OGXI | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Buy | M | 0.00 | 42 | 0 | 1,852 | 1.8 K to 1.9 K (+2.32 %) |
| Sep 21 2018 | OGXI | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Option Exercise | A | 2.56 | 37,000 | 94,720 | 37,000 | |
| Aug 15 2018 | OGXI | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 1,370 | 0 | 4,110 | |
| Aug 15 2018 | OGXI | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 43 | 0 | 42 | |
| Aug 15 2018 | OGXI | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 45 | 0 | 0 | |
| Aug 15 2018 | OGXI | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 28 | 0 | 0 | |
| Aug 15 2018 | OGXI | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Payment of Exercise | F | 2.78 | 472 | 1,312 | 1,810 | 2.3 K to 1.8 K (-20.68 %) |
| Aug 15 2018 | OGXI | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Buy | M | 0.00 | 1,486 | 0 | 2,282 | 796 to 2.3 K (+186.68 %) |
| Jul 30 2018 | OGXI | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Option Exercise | A | 3.37 | 20,000 | 67,400 | 20,000 | |
| Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Option Exercise | A | 4.57 | 274,000 | 1,252,180 | 274,000 | |
| Aug 03 2017 | OGXI | ACHIEVE LIFE SCIEN ... | JACOBS CINDY | EVP, CMO | Option Exercise | A | 0.00 | 54,800 | 0 | 54,800 | |
| Jun 14 2017 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 5,000 | 0 | 5,000 | |
| Jun 14 2017 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Payment of Exercise | F | 0.36 | 1,633 | 588 | 87,726 | 89.4 K to 87.7 K (-1.83 %) |
| Jun 14 2017 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Buy | M | 0.00 | 5,000 | 0 | 89,359 | 84.4 K to 89.4 K (+5.93 %) |
| Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 4,687 | 0 | 9,375 | |
| Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 3,125 | 0 | 3,125 | |
| Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 2,500 | 0 | 0 | |
| Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Payment of Exercise | F | 0.63 | 3,369 | 2,122 | 84,359 | 87.7 K to 84.4 K (-3.84 %) |
| Jan 12 2017 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Buy | M | 0.00 | 10,312 | 0 | 87,728 | 77.4 K to 87.7 K (+13.32 %) |
| Jun 15 2016 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 5,000 | 0 | 10,000 | |
| Jun 15 2016 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Sell | S | 1.03 | 1,437 | 1,473 | 77,416 | 78.9 K to 77.4 K (-1.82 %) |
| Jun 15 2016 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Buy | M | 0.00 | 5,000 | 0 | 78,853 | 73.9 K to 78.9 K (+6.77 %) |
| Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | A | 0.85 | 135,000 | 114,750 | 135,000 | |
| Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 4,688 | 0 | 14,062 | |
| Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 3,125 | 0 | 6,250 | |
| Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 2,500 | 0 | 2,500 | |
| Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 1,875 | 0 | 0 | |
| Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Sell | S | 0.83 | 3,254 | 2,701 | 73,853 | 77.1 K to 73.9 K (-4.22 %) |
| Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Buy | M | 0.00 | 12,188 | 0 | 77,107 | 64.9 K to 77.1 K (+18.77 %) |
| Jun 16 2015 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 5,000 | 0 | 15,000 | |
| Jun 16 2015 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Sell | S | 2.69 | 1,408 | 3,788 | 64,919 | 66.3 K to 64.9 K (-2.12 %) |
| Jun 16 2015 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Buy | M | 0.00 | 5,000 | 0 | 66,327 | 61.3 K to 66.3 K (+8.15 %) |
| May 21 2015 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | A | 1.86 | 37,500 | 69,750 | 37,500 | |
| May 21 2015 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | A | 0.00 | 18,750 | 0 | 18,750 | |
| May 21 2015 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 3,125 | 0 | 9,375 | |
| May 21 2015 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 2,500 | 0 | 5,000 | |
| May 21 2015 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 1,875 | 0 | 1,875 | |
| May 21 2015 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Sell | S | 1.88 | 2,092 | 3,933 | 61,327 | 63.4 K to 61.3 K (-3.30 %) |
| May 21 2015 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Buy | M | 0.00 | 7,500 | 0 | 63,419 | 55.9 K to 63.4 K (+13.41 %) |
| Jul 14 2005 | CRXA | CORIXA CORP | JACOBS CINDY | Sr. VP, Clinical De ... | Option Exercise | D | 17.00 | 10,938 | 185,946 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | JACOBS CINDY | Sr. VP, Clinical De ... | Option Exercise | D | 15.07 | 36,208 | 545,655 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | JACOBS CINDY | Sr. VP, Clinical De ... | Option Exercise | D | 13.45 | 70,891 | 953,484 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | JACOBS CINDY | Sr. VP, Clinical De ... | Option Exercise | D | 9.50 | 9,672 | 91,884 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | JACOBS CINDY | Sr. VP, Clinical De ... | Option Exercise | D | 6.41 | 10,936 | 70,100 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | JACOBS CINDY | Sr. VP, Clinical De ... | Option Exercise | D | 6.04 | 19,406 | 117,212 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | JACOBS CINDY | Sr. VP, Clinical De ... | Option Exercise | D | 5.70 | 68,750 | 391,875 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | JACOBS CINDY | Sr. VP, Clinical De ... | Option Exercise | M | 3.95 | 99,868 | 394,479 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | JACOBS CINDY | Sr. VP, Clinical De ... | Option Exercise | D | 17.00 | 4,062 | 69,054 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | JACOBS CINDY | Sr. VP, Clinical De ... | Option Exercise | D | 15.07 | 9,292 | 140,030 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | JACOBS CINDY | Sr. VP, Clinical De ... | Option Exercise | D | 13.45 | 4,109 | 55,266 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | JACOBS CINDY | Sr. VP, Clinical De ... | Option Exercise | D | 9.50 | 35,328 | 335,616 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | JACOBS CINDY | Sr. VP, Clinical De ... | Option Exercise | D | 6.41 | 4,064 | 26,050 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | JACOBS CINDY | Sr. VP, Clinical De ... | Option Exercise | D | 6.04 | 21,094 | 127,408 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | JACOBS CINDY | Sr. VP, Clinical De ... | Option Exercise | M | 3.95 | 132 | 521 | 0 | |
| Jul 14 2005 | CRXA | CORIXA CORP | JACOBS CINDY | Sr. VP, Clinical De ... | Sell | D | 4.40 | 132 | 581 | 0 | 132 to 0 (-100.00 %) |
| Jul 14 2005 | CRXA | CORIXA CORP | JACOBS CINDY | Sr. VP, Clinical De ... | Buy | M | 3.95 | 132 | 521 | 132 | 0 to 132 |
| Jul 14 2005 | CRXA | CORIXA CORP | JACOBS CINDY | Sr. VP, Clinical De ... | Sell | D | 4.40 | 99,868 | 439,419 | 0 | 99.9 K to 0 (-100.00 %) |
| Jul 14 2005 | CRXA | CORIXA CORP | JACOBS CINDY | Sr. VP, Clinical De ... | Buy | M | 3.95 | 99,868 | 394,479 | 99,868 | 0 to 99.9 K |
| Jan 03 2005 | CRXA | CORIXA CORP | JACOBS CINDY | Sr. VP, Clinical De ... | Option Exercise | A | 3.95 | 99,868 | 394,479 | 99,868 | |
| Jan 03 2005 | CRXA | CORIXA CORP | JACOBS CINDY | Sr. VP, Clinical De ... | Option Exercise | A | 3.95 | 132 | 521 | 132 |
Page: 1